A Clinical study to assess the effect of Ayurvedic treatment comprising Madhutailika Basti Dhanyamla dhara and Atibalamoola & Bhoomyamalaki drugs in the patient of Diabetic polyneurotpathy

Evaluation of Madhutailika Basti and Ayurvedic treatment regime in the management of Diabetic polyneuropathy â?? Randomized Controlled Clinical Trial

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/04/008367

Enrollment

100

Registered

2017-04-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetes Mellitus type 2 Diabetic Polyneuropathy Health Condition 2: E114- Type 2 diabetes mellitus with neurological complications Health Condition 3: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Madhutailika basti, Dhanyamla dhara and shamana: Madhutailika basti will be given per rectally OD for 8 days, Dhanyamla made warm will be poured over the affected part OD for 15 days, B

Eligibility

Inclusion criteria

Inclusion criteria: 1. Longstanding and uncontrolled Diabetes mellitus along with the presence of symptoms and signs of Diabetic peripheral neuropathy (polyneuropathy). 2. Symptoms may include: a.) Decreased sensation b.) Positive neuropathic sensory symptoms predominantly in the toes, feet or legs. 3. Signs may include: a.) Decreased distal sensation b.) Unequivocally decreased or absent ankle reflexes.

Exclusion criteria

Exclusion criteria: Patients with - 1. Ischemic heart diseases 2. Non-Diabetic Neuropathies 3. Acute complications of DM 4. Any kind of infection 5. Diabetic foot 6. Piles 7. Fissures 8. Fistulas 9. Myocardial Infarction 10.Cerebrovascular event 11.Cardiac arrhythmias 12.Pregnancy 13.Active malignant disease

Design outcomes

Primary

Measure	Time frame
Toronto Clinical Scoring System (TCSS) for Diabetic PolyneuropathyTimepoint: 45 days	—

Secondary

Measure	Time frame
Quality of lifeTimepoint: 45 days	—

Countries

India

Contacts

Public ContactRahul S Gandhi

Institute for Post Graduate Teaching and Research in Ayurveda

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026